Odyssey Therapeutics, Inc. ODTX

Full chart Compare
Set alert

Price alert · ODTX

All alert types
19.50 USD -2.07 (-9.60%)

At closeNov 4, 2026, 4:00 PM EST

19.50 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

19.00 Day range 22.36
15.10 52-week range 29.05
YTD
+18.76%
1 year
+18.76%

Financial health

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -3.0×
FY 2025: -3.0×
FY 2025 5y median -3.0× FY 2025
P/S 152×
FY 2025: 152×
FY 2025 5y median 152× FY 2025
P/B -0.9×
FY 2025: -0.9×
FY 2025 5y median -0.9× FY 2025
P/FCF -3.5×
FY 2025: -3.5×
FY 2025 5y median -3.5× FY 2025
EV/EBITDA -3.0×
FY 2025: -3.0×
FY 2025 5y median -3.0× FY 2025
EV/Sales 147×
FY 2025: 147×
FY 2025 5y median 147× FY 2025
FCF Yield -28.9%
FY 2025: -28.9%
FY 2025 5y median -28.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2025: 100.0%
FY 2025 5y median 100.0% FY 2025
Operating Margin -5415.2%
FY 2025: -5415.2%
FY 2025 5y median -5415.2% FY 2025
Net Margin -4994.9%
FY 2025: -4994.9%
FY 2025 5y median -4994.9% FY 2025
ROE 30.4%
FY 2025: 30.4%
FY 2025 5y median 30.4% FY 2025
ROIC -64.4%
FY 2025: -64.4%
FY 2025 5y median -64.4% FY 2025
ROA -55.1%
FY 2025: -55.1%
FY 2025 5y median -55.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025: 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025: 0.0%
FY 2025 FY 2025

Financial Health

Current Ratio 7.2×
FY 2025: 7.2×
FY 2025 5y median 7.2× FY 2025
Quick Ratio 7.2×
FY 2025: 7.2×
FY 2025 5y median 7.2× FY 2025
Debt / Equity -0.1×
FY 2025: -0.1×
FY 2025 5y median -0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2025: 0.1×
FY 2025 5y median 0.1× FY 2025
Interest Coverage -9480×
FY 2025: -9480×
FY 2025 5y median -9480× FY 2025

Dividends

Dividend Yield 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025: 0.0%
FY 2025 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31